ZIM Laboratories Limited (ZIMLAB.BO)

105.25 +0.25 (+0.24%) As of 10:32AM IST. Market open.

ZIM Laboratories Limited

B 21 – 22 MIDC Area
Kalmeshwar
Nagpur 441501
India
91 71 1827 1370
https://www.zimlab.in

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 556

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Anwar Siraj Daud M.Pharm	Chairman of The Board and Managing Director	17.78M	N/A	N/A
Mr. Shyam Mohan Patro	Chief Financial Officer	N/A	N/A	N/A
Mr. Piyush Siddheshwar Nikhade	Company Secretary & Compliance Officer	N/A	N/A	N/A
Mr. Niraj Pukhraj Dhadiwal	Director of Business Development & Executive Director	9.32M	N/A	1967
Mr. Zulfiquar Murtaza Kamal	Director of Finance & Executive Director	11.02M	N/A	1961
Mr. Prakash Pralhadrao Sapkal BPharm, MBA	Head of ODS Business, Formulations of Domestic, ROW & Emerging Markets & Director	8.68M	N/A	1968
Mr. Pradeep Kataria	Senior Vice President of Operations	N/A	N/A	N/A
Mr. Vijay Fudke	Senior Vice President of Technical Services	N/A	N/A	N/A

Amounts are as of 31 December 2024, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. The company provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. It offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was incorporated in 1984 and is based in Nagpur, India.

Corporate governance

ZIM Laboratories Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.